Literature DB >> 16144230

Lessons from European population genetic databases: comparing the law in Estonia, Iceland, Sweden and the United Kingdom.

Susan M C Gibbons1, Hördur Helgi Helgason, Jane Kaye, Ants Nõmper, Lotta Wendel.   

Abstract

The advent of large-scale, population genetic databases (PGDs) in several countries around the world marks a significant development in human DNA banking and genetic research. The European countries that have led the way in the development of PGDs are Iceland, Sweden, Estonia and the U.K. In legal terms, the emergence of PGDs has been far from straightforward as such projects pose a range of difficult and complex issues for the law to address. This article canvasses the current law in Iceland, Estonia, Sweden and the U.K. on four fundamental issues of principle pertaining to PGDs, in order to illustrate the difficulties that have emerged around PGDs, highlight key areas of legal concern, and shed light on possible ways forward. It compares and contrasts the differing legal positions and lawmakers' responses to date in these four European countries that have established PGDs or are seeking to do so. The four fundamental issues examined are: (1) consent, especially for secondary research purposes; (2) ownership of biological samples, data and databases; (3) the rights of certain third parties to gain access to, and to use, PGD biological samples and data; and (4) benefit sharing, including the provision of feedback and genetic counselling to participants. This analysis may offer some guidance for policymakers in other jurisdictions where PGDs have been proposed or are being established.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach

Mesh:

Year:  2005        PMID: 16144230     DOI: 10.1163/1571809054640659

Source DB:  PubMed          Journal:  Eur J Health Law        ISSN: 0929-0273


  4 in total

1.  Legal and ethical consequences of international biobanking from a national perspective: the German BMB-EUCoop project.

Authors:  Jürgen W Goebel; Thomas Pickardt; Maren Bedau; Michael Fuchs; Christian Lenk; Inga Paster; Tarde M Spranger; Ulrich Stockter; Ulrike Bauer; David N Cooper; Michael Krawczak
Journal:  Eur J Hum Genet       Date:  2009-12-02       Impact factor: 4.246

2.  Withdrawal from biobank research: considerations and the way forward.

Authors:  Kristina Hug; Göran Hermerén; Mats Johansson
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

3.  Ethical and Legal Issues in Biobanking for Genomic Research in Nigeria.

Authors:  Simisola O Akintola
Journal:  BEOnline       Date:  2012

4.  Informed consent in the genomics era.

Authors:  Deborah Mascalzoni; Andrew Hicks; Peter Pramstaller; Matthias Wjst
Journal:  PLoS Med       Date:  2008-09-16       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.